✦ LIBER ✦

Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension

✍ Scribed by Hossein A Ghofrani; Joanna Pepke-Zaba; Joan A Barbera; Richard Channick; Anne M Keogh; Miguel A Gomez-Sanchez; Meinhard Kneussl; Friedrich Grimminger

Book ID: 119264081
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 170 KB
Volume: 43
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2004.02.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phosphodiesterase type 5 inhibitors in p

Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension

✍ David Montani; Marie-Camille Chaumais; Laurent Savale; Delphine Natali; Laura C. 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 216 KB

Nitric oxide and pulmonary arterial pres

Nitric oxide and pulmonary arterial pressures in pulmonary hypertension

✍ Roberto F. Machado; Medha-vini Londhe Nerkar; Raed A. Dweik; Jeffrey Hammel; All 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 270 KB

Long-term Inhaled Nitric Oxide Plus Phos

Long-term Inhaled Nitric Oxide Plus Phosphodiesterase 5 Inhibitors for Severe Pulmonary Hypertension

✍ Gregorio Miguel Pérez-Peñate; Gabriel Juliá-Serdà; Nazario Ojeda-Betancort; Anto 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 646 KB

Vasoreactivity Testing with Inhaled Ilop

Vasoreactivity Testing with Inhaled Iloprost and Nitric Oxide in Pulmonary Arterial Hypertension

✍ J. Phan; P. Macdonald; A. Keogh; E. Kotlyar; R. Pritchard; C. Hayward 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Nitric oxide in systemic and pulmonary h

Nitric oxide in systemic and pulmonary hypertension

✍ Hsing I. Chen; Cheng-Tao Hu; Chia-Yen Wu; David Wang 📂 Article 📅 1997 🏛 BioMed Central 🌐 English ⚖ 793 KB

Inhaled nitric oxide reduces pulmonary a

Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension

✍ Findlay, James Y. ;Harrison, Barry A. ;Plevak, David J. ;Krowka, Michael J. 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 85 KB

## Pulmonary artery hypertension in association with liver failure (portopulmonary hypertension [PPHTN] ) is a significant barrier to liver transplantation because patients with this condition have a very high mortality when transplantation is undertaken. Inhaled nitric oxide (NO), a potent pulmon